Wilson Sonsini tops Life Sciences Law Firm Index for 2nd straight year
The Life Sciences Law Firm Index identifies the most active and relevant firms for life science companies.
presented by
Finding a way through a tight deal space
Leaders of WilmerHale’s life sciences practice share trends they see regarding acquisitions and initial public offerings.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
presented by
Navigating the Life Science M&A Savannah
Still recovering from a market correction two years ago, and with a scarcity of attractive targets and ongoing macroeconomic uncertainty, the life sciences dealmaking space is in a state of flux.
presented by
Collaboration at Fenwick & West Steers Firm through complex deals
After a relatively slow 2016 for life sciences deals...
presented by
Newly united Arnold & Porter Kaye Scholer surveys changed life sciences deal environment
Last year proved a slow one for dealmaking in the life sciences space. But that didn’t stop two of the major legal players in it from consummating one themselves: In November, Arnold & Porter and Kaye Scholer agreed to merge, bringing together two formidable healthcare practices.
Insurance Companies Can Find Relief During Delay of Loss Reimbursement
Lake Whillans is providing financial relief to insurance companies that offered plans on the Affordable Care Act’s health insurance exchanges and are now impaired by the government’s delay in making promised so-called “risk corridor payments.”
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Personal Touch In Patent Prosecution
When it comes to fighting disease, Michael Shuster takes things personally...
Aggregate Spend Goes Global
This independent editorial series on healthcare and the law is sponsored by Lake Whillans, a distressed venture capital and litigation finance firm that helps companies facing litigation or arbitration. As states began to jump onto the pharmaceutical regulation bandwagon around the turn of the century, Porzio Bromberg & Newman brought John Ohoro on to help clients sift […]
Friends and Family (Offices) Step in to Funding Drought
Not too long ago, it didn’t take much for someone with an idea for a new medical device to rake in the early-stage funding. Investors have been a bit more discerning over the past decade, to say the least, and by and large they remain so, according to K&L Gates’ Michael Hedge, who’s been around long enough to […]
M&A: The Last Refuge for Biotechs Seeking Funding
These are tough times in the biotech and pharmaceutical industries: Funding is drying up, investors are fleeing the space, the IPO door is pretty firmly shut, valuations are dropping, activists are lurking and the headlines are anything but kind. But when the going gets tough, the tough consider strategic alternatives. Stuart Falber and Belinda Juran, […]
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Wilson Sonsini, WilmerHale and Cooley top new Life Sciences Law Firm Index
The life sciences — particularly in biotechnology and pharmaceuticals — are among the very few industries where companies insist on industry-specialized advisors. The complex life cycle of a life sciences product demands a broad range of legal and business expertise across many practice specialties, combined with deep scientific knowledge. The stakes are increasing particularly when […]
Meet the Mt. Rushmore of healthcare corporate venture capital
Throughout the year Lake Whillans, with the help of MedCity News, has explored two key issues for healthcare investors and entrepreneurs: trust and reliability. We’ve helped bring to light some harrowing war stories of partnerships gone bad. We’ve also asked healthcare leaders in the trenches about the best ways to operate in the modern healthcare […]
Healthcare’s corporate investors are like backup quarterbacks (proceed with caution)
Everyone loves the backup quarterback because they’ve never played a down. But once those backups play, the sports analogy goes, and they are almost always worse than the starter. Are digital health VCs the backup quarterbacks of healthcare investing? Rightfully, there’s a lot of excitement about corporate venture’s increasing prominence in healthcare. But don’t get […]
McKesson, Blue Cross top digital health’s most trusted corporate VCs
Part II in our research examining which corporate venture capitalists you can trust and rely on.
Startups: Know when you’re valuable, know when you’re not – and remember to take notes
If you run a startup, do these three rules resonate?